MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer

Oncogene

Volumn 30, Issue 47, 2011, Pages 4750-4756

  Braconi, C ^a   Kogure, T ^a,b   Valeri, N ^a   Huang, N ^a   Nuovo, G ^c   Costinean, S ^a   Negrini, M ^d   Miotto, E ^d   Croce, C M ^a   Patel, T ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

HCC; MEG3; Methylation; Non coding RNA

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GENE PRODUCT; MICRORNA; PROTEIN MEG3; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN GENOME; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; MEG3 GENE; METHYLATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA TRANSCRIPTION; TISSUE SPECIFICITY;

CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; ORGAN SPECIFICITY; PROTEINS; RNA, UNTRANSLATED;

MURINAE; MUS;

EID: 81855183267     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.193     Document Type: Article

References (36)

1. Benetatos L, Dasoula A, Hatzimichael E, Georgiou I, Syrrou M, Bourantas KL. (2008). Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma 8: 171-175.
2. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M et al. (2010). CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 34: 148-153.
3. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G et al. (2010). Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin Cancer Res 16: 957-966.
4. Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ et al. (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA 108: 786-791.
5. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. (1990). Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 1973-1977.
6. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H, Franco D et al. (2004). Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 41: 292-298.
7. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
8. Croce CM. (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
9. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104: 15805-15810.
10. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E et al. (2009). MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418.
11. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA et al. (2009). MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081.
12. Hagan JP, O'Neill BL, Stewart CL, Kozlov SV, Croce CM. (2009). At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One 4: e4352.
13. Huarte M, Rinn JL. (2010). Large non-coding RNAs: missing links in cancer? Hum Mol Genet 19: R152-R161.
14. Kawaji H, Severin J, Lizio M, Forrest AR, van NE, Rehli M et al. (2011). Update of the FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. Nucleic Acids Res 39: D856-D860.
15. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S et al. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
16. Louro R, Smirnova AS, Verjovski-Almeida S. (2009). Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 93: 291-298.
17. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Seti F et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
18. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Caspedes M, Blanco D et al. (2008). A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561.
19. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R et al. (2010). CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29: 6390-6401.
20. Matouk IJ, Degroot N, Mezan S, Ayesh S, bu-Lail R, Hochberg A et al. (2007). The H19 non-coding RNA is essential for human tumor growth. PLoS One 2: e845.
21. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
22. Mercer TR, Dinger ME, Mattick JS. (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159.
23. Oliva J, Bardag-Gorce F, French BA, Li J, French SW. (2009). The regulation of non-coding RNA expression in the liver of mice fed DDC. Exp Mol Pathol 87: 12-19.
24. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G et al. (2010). Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
25. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM et al. (2007). Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132: 330-342.
26. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B et al. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107: 264-269.
27. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. (2010). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
28. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y et al. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142.
29. Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T et al. (2009). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 50: 1152-1161.
30. Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H et al. (2010). Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 31: 208-215.
31. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH et al. (2010). Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845.
32. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y et al. (2010a). Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70: 2350-2358.
33. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y et al. (2010b). Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151: 939-947.
34. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR et al. (2003). A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88: 5119-5126.
35. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A. (2005). Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 90: 2179-2186.
36. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R et al. (2007). Activation of p53 by MEG3 non-coding RNA. J Biol Chem 282: 24731-24742.